Porphyria prevention study tests Panhematin's power
NCT ID NCT02922413
First seen Feb 01, 2026 · Last updated Apr 30, 2026 · Updated 17 times
Summary
This study tested whether Panhematin (hemin) can safely prevent acute attacks in people with certain types of porphyria. Researchers gave 13 participants either Panhematin or a placebo and tracked how many had attacks and serious side effects. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE INTERMITTENT PORPHYRIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas Medical Branch
Galveston, Texas, 77555, United States
Conditions
Explore the condition pages connected to this study.